| CSS01043 | 重组人干扰素α－2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | New Drug Application | 2001-09-28 | 上海华新生物技术有限公司 | Shanghai Huaxin High Biotechnology Inc | Approval Completed-Pending Certificated | 2002-12-31 | view |
| CSS01044 | 重组人干扰素α－2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | New Drug Application | 2001-09-28 | 上海华新生物技术有限公司 | Shanghai Huaxin High Biotechnology Inc | Approval Completed-Pending Certificated | 2002-12-31 | view |
| CYSB2000117 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2020-05-29 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | In Review | 2020-05-28 | view |
| CXSL1600023 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products(14) | New Drug Application | 2016-03-30 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2017-02-13 | view |
| CXSB0800043 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2008-10-23 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2009-04-08 | view |
| CSS00067 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products(4) | New Drug Application | 2000-12-08 | 北京远策药业有限责任公司 | Beijing Yuance Pharmaceutical Co Ltd | Certificate Issued | 2001-10-30 | view |
| CYSB1800229 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2018-10-29 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2020-10-27 | view |
| CYSB1000214 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2011-02-25 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2013-11-20 | view |
| X0304744 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2003-09-10 | 安徽安科生物工程股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2004-03-01 | view |
| CYSB1500472 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2016-06-06 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2016-11-17 | view |
| CYSB1100541 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2012-06-20 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2013-02-19 | view |
| CYSB2000116 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2020-05-29 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | In Review | 2020-05-28 | view |
| CXSL1600024 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products(14) | New Drug Application | 2016-03-30 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2017-02-13 | view |
| CYSB1000630 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2011-06-01 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2014-07-24 | view |
| CSb20020109 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products(4) | Supplementary Application | 2002-08-07 | 天津华立达生物工程有限公司 | Tianjin Sinobioway Biomedicine Co Ltd | Certificate Issued | 2003-01-24 | view |
| CXSB0800044 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2008-10-23 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2009-04-08 | view |
| CYSB1800228 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2018-10-29 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2020-10-27 | view |
| CYSB1000216 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2011-02-25 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2013-11-20 | view |
| CYSB1500473 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2016-06-06 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2016-11-17 | view |
| CYSB1200063 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2012-03-23 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2013-04-23 | view |
